Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2019 1
2020 1
2021 6
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sheu m (535 results)?
The burden of surgical site infections and related antibiotic resistance in two geographic regions of Sierra Leone: a prospective study.
Lakoh S, Yi L, Russell JBW, Zhang J, Sevalie S, Zhao Y, Kanu JS, Liu P, Conteh SK, Williams CEE, Barrie U, Sheku MG, Jalloh MB, Adekanmbi O, Jiba DF, Kamara MN, Deen GF, Okeibunor JC, Yendewa GA, Guo X, Firima E. Lakoh S, et al. Among authors: sheku mg. Ther Adv Infect Dis. 2022 Dec 7;9:20499361221135128. doi: 10.1177/20499361221135128. eCollection 2022 Jan-Dec. Ther Adv Infect Dis. 2022. PMID: 36518726 Free PMC article. Review.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
Attitudes toward COVID-19 Vaccination: Staff and Patient Perspectives at Six Health Facilities in Sierra Leone.
Joseph SA, Jerome JG, Boima F, Pognon PR, Fejfar D, Dibba Y, Lavalie D, Barrie MB, Oteju A, Sheku M, Mahmoud M, Mattia J, Barnhart DA; Cross-Site COVID-19 Cohort Technical Group. Joseph SA, et al. Among authors: sheku m. Vaccines (Basel). 2023 Aug 19;11(8):1385. doi: 10.3390/vaccines11081385. Vaccines (Basel). 2023. PMID: 37631953 Free PMC article.
An Intra-COVID-19 Assessment of Hand Hygiene Facility, Policy and Staff Compliance in Two Hospitals in Sierra Leone: Is There a Difference between Regional and Capital City Hospitals?
Lakoh S, Firima E, Williams CEE, Conteh SK, Jalloh MB, Sheku MG, Adekanmbi O, Sevalie S, Kamara SA, Kamara MAS, Barrie U, Kamara GN, Yi L, Guo X, Haffner C, Kamara MN, Jiba DF, Namanaga ES, Maruta A, Kallon C, Kanu JS, Deen GF, Samai M, Okeibunor JC, Russell JBW. Lakoh S, et al. Among authors: sheku mg. Trop Med Infect Dis. 2021 Nov 29;6(4):204. doi: 10.3390/tropicalmed6040204. Trop Med Infect Dis. 2021. PMID: 34941660 Free PMC article.
Seroprevalence of hepatitis B and hepatitis C among blood donors in Sierra Leone: A multi-year retrospective study.
Tognon F, Sevalie S, Gassimu J, Sesay J, Hann K, Sheku M, Bearse E, Di Gennaro F, Marotta C, Pellizzer G, Putoto G, Lado M, Franke MF, Dibba Y, Gevao S, Beynon F, Mesman AW. Tognon F, et al. Among authors: sheku m. Int J Infect Dis. 2020 Oct;99:102-107. doi: 10.1016/j.ijid.2020.07.030. Epub 2020 Jul 25. Int J Infect Dis. 2020. PMID: 32717396 Free article.
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
Ishola D, Manno D, Afolabi MO, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Leyssen M, Greenwood B, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group. Ishola D, et al. Lancet Infect Dis. 2022 Jan;22(1):97-109. doi: 10.1016/S1473-3099(21)00125-0. Epub 2021 Sep 13. Lancet Infect Dis. 2022. PMID: 34529963 Free PMC article. Clinical Trial.
13 results